GlassScriptPhysician profile
James P Doran
NPI 1992182612
$14,653.26
in general payments reported to CMS, 2019-2025
14 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $68.72 · 2021: $9,544 · 2022: $4,342 · 2023: $185 · 2024: $308 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,966.68 | 2021-2022 | |
| Medical Device Business Services, INC. | $2,991.23 | 2021-2022 | |
| Liberty Surgical INC. | $2,099.17 | 2021-2022 | |
| Stryker Corporation | $1,466.97 | 2021-2025 | Accolade, Trident, Triathlon |
| Depuy Synthes Sales INC. | $653.72 | 2021-2025 | Monovisc, Orthovisc |
| Eclipse Technology Solutions INC. | $142.10 | 2024 | |
| Globus Medical, INC. | $89.45 | 2024 | Ankle Fracture System, Clavicular Fracture Fixation |
| Zynex Medical, INC. | $77.75 | 2025 | Nexwave |
| Smith+Nephew, INC. | $68.72 | 2020 | |
| Bioventus LLC | $24.63 | 2025 | Xcell |
| Integra Lifesciences Corporation | $20.88 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Djo, LLC | $17.64 | 2025 | Donjoy |
| Linvatec Corporation | $17.48 | 2023 | Biobrace 23mm |
| Ferring Pharmaceuticals INC. | $16.84 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Doran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.